Control of contact-inhibition by 4E-BP1 upregulation

Cell Cycle

Volumn 9, Issue 7, 2010, Pages 1241-1245

  Azar, Rania ^a,c   Susini, Christiane ^a   Bousquet, Corinne ^a   Pyronnet, Stéphane ^a,b  

^a INSERM   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c LEBANESE UNIVERSITY   (Lebanon)

Author keywords

4E BP1; Cell cycle; Contact inhibition; Cyclin D1; Translation initiation

Indexed keywords

CYCLIN D1; INITIATION FACTOR 4E BINDING PROTEIN 1;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DENSITY; CELL PROLIFERATION; CELL TYPE; CONTACT INHIBITION; DOWN REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION;

EID: 77953589764     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.7.11047     Document Type: Article

References (22)

1. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136:731-45.
2. Prévôt D, Décimo D, Herbreteau CH, Roux F, Garin J, Darlix JL, Ohlmann T. Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning. EMBO J 2003; 22:1909-21. (Pubitemid 36460147)
3. Hinnebusch AG. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci 2006; 31:553-62.
4. Prévôt D, Darlix JL, Ohlmann T. Conducting the initiation of protein synthesis: the role of eIF4G. Biol Cell 2003; 95:141-56.
5. Pyronnet S, Sonenberg N. Cell cycle-dependent translational control. Curr Opin Genet Dev 2001; 11:13-8.
6. Sivan G, Elroy-Stein O. Regulation of mRNA Translation during cellular division. Cell Cycle 2008; 7:741-4. (Pubitemid 351520036)
7. Pyronnet S, Pradayrol L, Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol Cell 2000; 5:607-16.
8. Heesom KJ, Gampel A, Mellor H, Denton RM. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr Biol 2001; 11:1374-9. (Pubitemid 32835880)
9. Galy B, Maret A, Prats AC, Prats H. Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoforms. Cancer Res 1999; 59:165-71. (Pubitemid 29062973)
10. Lahlou H, Fanjul M, Pradayrol L, Susini C, Pyronnet S. Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol Cell Biol 2005; 25:4034-45. (Pubitemid 40617652)
11. Shantz LM, Pegg AE. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 1994; 54:2313-6.
12. Pyronnet S, Vagner S, Bouisson M, Prats AC, Vaysse N, Pradayrol L. Relief of ornithine decarboxylase messenger RNA translational repression induced by alternative splicing of its 5' untranslated region. Cancer Res 1996; 56:1742-5. (Pubitemid 26118206)
13. Azar R, Alard A, Susini C, Bousquet C, Pyronnet S. 4E-BP1 is a target of Smad4 essential for TGFbeta-mediated inhibition of cell proliferation. EMBO J 2009; 28:3514-22.
14. Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ, et al. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J Biol Chem 1995; 270:21176-80.
15. Averous J, Fonseca BD, Proud CG. Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. Oncogene 2008; 27:1106-13. (Pubitemid 351253179)
16. Konicek BW, Dumstorf CA, Graff JR. Targeting the eIF4F translation initiation complex for cancer therapy. Cell Cycle 2008; 7:2466-71.
17. Kozar K, Sicinski P. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 2005; 4:388-91. (Pubitemid 41359721)
18. Chassot AA, Lossaint G, Turchi L, Meneguzzi G, Fisher D, Ponzio G, Dulic V. Confluence-induced cell cycle exit involves pre-mitotic CDK inhibition by p27(Kip1) and cyclin D1 downregulation. Cell Cycle 2008; 7:2038-46. (Pubitemid 352030350)
19. Mavrakis KJ, Wendel HG. Translational control and cancer therapy. Cell Cycle 2008; 7:2791-4.
20. Galés C, Sanchez D, Poirot M, Pyronnet S, Buscail L, Cussac D, et al. High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor. Oncogene 2003; 22:6081-9. (Pubitemid 37175886)
21. Pyronnet S, Pradayrol L, Sonenberg N. Alternative splicing facilitates internal ribosome entry on the ornithine decarboxylase mRNA. Cell Mol Life Sci 2005; 62:1267-74. (Pubitemid 40880130)
22. Azar R, Najib S, Lahlou H, Susini C, Pyronnet S. Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1. Cell Mol Life Sci 2008; 65:3110-7.